Account 6-(1-Methyl-1H-pyrazol-4-yl)-3-((2-methyl-2H-indazol-5-yl)thio)-[1,2,4]triazolo[4,3-b]pyridazine
- Catalog No. :
- ACGJVK305
- CAS No. :
- 1357072-61-7
- Molecular Formula :
- C17H14N8S
- Molecular Weight :
- 362.42
IUPAC Name:6-(1-methyl-1H-pyrazol-4-yl)-3-((2-methyl-2H-indazol-5-yl)thio)-[1,2,4]triazolo[4,3-b]pyridazine
![6-(1-Methyl-1H-pyrazol-4-yl)-3-((2-methyl-2H-indazol-5-yl)thio)-[1,2,4]triazolo[4,3-b]pyridazine structure diagram](/images/productimg/no-pic.svg)
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
10mg98%$53.00Login to see priceInquiryInquiry
25mg98%$91.00Login to see priceIn stockInquiry
50mg98%$150.00Login to see priceIn stockInquiry
100mg98%$238.00Login to see priceIn stockInquiry
250mg98%$407.00Login to see priceIn stockInquiry
1g98%$1301.00Login to see priceIn stockInquiry
Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.
0 Reviews:View Reviews
Product Information
| Product Name | 6-(1-Methyl-1H-pyrazol-4-yl)-3-((2-methyl-2H-indazol-5-yl)thio)-[1,2,4]triazolo[4,3-b]pyridazine |
|---|---|
| IUPAC Name | 6-(1-methyl-1H-pyrazol-4-yl)-3-((2-methyl-2H-indazol-5-yl)thio)-[1,2,4]triazolo[4,3-b]pyridazine |
| MDL No. | MFCD26960936 |
| Molecular Formula | C17H14N8S |
| Molecular Weight | 362.42 |
| SMILES | CN1N=C2C=CC(SC3=NN=C4C=CC(C5=CN(C)N=C5)=NN43)=CC2=C1 |
| InChI Key | JYXHZDNTBJUJNH-UHFFFAOYSA-N |
| Synonym | CS-1422;c-Met inhibitor 1;6-(1-METHYL-1H-PYRAZOL-4-YL)-3-((2-METHYL-2H-INDAZOL-5-YL)THIO)-[1,2,4]TRIAZOLO[4,3-B]PYRIDAZINE;3-[(2-Methyl-2H-indazol-5-yl)thio]-6-(1-methyl-1H-pyrazol-4-yl)-1,2,4-triazolo[4,3-b]pyridazine;c-Met inhibitor;1,2,4-Triazolo[4,3-b]pyridazine, 3-[(2-methyl-2H-indazol-5-yl)thio]-6-(1-methyl-1H-pyrazol-4-yl)-;c-Met/HGFR,c Met inhibitor 1,c-Met inhibitor 1,inhibit,Inhibitor,cMet inhibitor 1;c-Met inhibitor 1, 10 mM in DMSO |
| CAS No. | 1357072-61-7 |
| PubChem CID | 56650915 |
Safety Data
- Pictogram
- Signal Word
- Warning
- Hazard Statement(s)
- H302-H315-H319-H335
- Precautionary Statement(s)
- P261-P305+P351+P338
